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INTRODUCTION
Fetus is a semi-allogenic tissue which relies inside
the body of a women whose immune-competent of
producing rejection immune response, therefore
modulation of maternal immune response is
required to maintain pregnancy.1
During pregnancy, many complications may
occur, which may lead to early termination of
pregnancy. Abortion is defined as the loss of
pregnancy either spontaneous or induction before
being viable (gestational age < 20 weeks). Abortion
can result in physical and emotional disturbance.
The incidence of spontaneous abortion is between
15-20% from all pregnancy. Predisposing factors
of spontaneous abortion include genetic factors,
anatomy, endocrine, immune, infection, throm-
bophilia, and idiophatic.2-4
Maternal immune response to fetus has an
important role as a predisposing factor in
spontaneous abortion, and it is often unexplain-
able. The current hypothesis is the presence of
multiple factors which may affect at systemic,
and local in utero, determine to modulate
i m m u n e  r e s p o n s e  i n t o  d e c r e a s i n g
inflammation response of trophoblasts. Factors
involved in this process are hormones ,
particularly progesterone, embryonic hormones,
and Natural Killer cells (NK cells).1,2
Abstract
Objective: To determine the role of progesterone-induced
blocking factor (PIBF) in women with threatened abortion.
Methods: This was a cross-sectional study. The blood serum of two
groups, the first one was women with normal gestation of  20
weeks, and the second one was those with imminent abortion in
Prof. Dr. R.D. Kandou Hospital, and Subcenter Hospital in Manado,
was collected. Samples were processed with PIBF ELISA-kit.
Results: PIBF serum value of women in normal gestation  20
weeks is (47.15323.830)ng/ml and threatened abortion is
(11.540 4.892) ng/ml, with p value = 0.000.
Conclusion: PIBF serum value of women with threatened abor-
tion is significantly lower compared to women of normal gestation
 20 weeks. This study showed that PIBF has an important role in
maintaining pregnancy and can be used as a biologic marker of a
pathologic process in pregnancy.
[Indones J Obstet Gynecol 2017; 5-4: 193-198]
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Abstrak
Tujuan: Mengetahui kadar PIBF serum perempuan hamil usia
kehamilan normal  20 minggu dan abortus iminens sehingga dapatmenambah pemahaman mengenai PIBF sebagai petanda biologis
patologi kehamilan, dan dalam upaya terapi rasional pasien dengan
abortus iminens.
Metode: Penelitian analitik komparatif potong lintang terhadap 32
pasien yang dibagi menjadi 2 kelompok kehamilan normal  20minggu, dan abortus iminens di RSUP Prof Dr. R.D. Kandou, beserta RS
Jejaring di wilayah Manado, dilakukan pengambilan sampel serum.Sampel dilakukan pemeriksaan kadar PIBF dengan ELISA-kit. Data
diproses menggunakan program SPSS versi 22.0.
Hasil: Kadar PIBF serum perempuan hamil usia kehamilan  20
minggu normal (47,15323,830)ng/ml dan abortus iminens (11,540
4,892) ng/ml (p=0,000).
Kesimpulan: Kadar PIBF serum perempuan hamil dengan abortusiminens lebih rendah secara bermakna dibandingkan kadar PIBF
serum perempuan hamil usia kehamilan  20 minggu normal. Hasil ini
menunjukkan bahwa PIBF berperanan dalam mempertahankankehamilan dan dapat digunakan sebagai sarana petanda adanya
proses patologis dalam suatu kehamilan.
[Maj Obstet Ginekol Indones 2017; 5-4: 193-198]
Kata kunci: abortus iminens, imunologi kehamilan, kehamilan muda,
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In daily clinical practice, progesterone
supplement is often used as a supportive
therapy for pregnant women who are diagnosed
with threatened abortion. Progesterone has
an important role in modulating immune response
in early trimester pregnancy through modulating
pro-inflammatory and anti-inflammatory
cytokines from conceptus, resulting in the
continuation or termination of pregnancy.
With the influence of progesterone, lymphocyte
releases protein called progesterone-induced
blocking factor (PIBF), which mediates the
modulation of immune response and the anti-
abortive effect of progesterone. This process also
gives positive feedback, there by increasing the
amount of progesterone receptors in the activated
lymphocyte in the placental cells and CD8+ cells. In
return the amount of PIBF will increase along with
the gestational age from week 6 to 36, and after
41 weeks, PIBF will decrease considerably and
induce the parturition. PIBF also inhibits
peripheral NK cells activity. The biological effects
of PIBF as mentioned above indicates that PIBF has
a role in maintaining pregnancy. Therefore, PIBF
value in the body liquid can predict the prognosis
of pregnancy.5
A Cochrane review in 2013 demonstrated that
there was no significant difference between
progesterone supplementation and placebo in
maintaining pregnancy. Nevertheless, Check JH
mentioned that although progesterone deficiency
occurs in one third of pregnancy, progesterone
supplementation to improve PIBF value still has a
role in decreasing 33% spontaneous abortion.6-8
Considering the impact of abortion in the physi-
cal and emotional aspects of the patient’s, and to
learn further the role of immune-endocrine (PIBF)
in affecting the prognosis of pregnancy, we are
interested in doing this study.
METHODS
This was a cross-sectional study. Subejcts were
pregnant women with gestational age of  20
weeks at Prof. Dr. R.D. Kandou Hospital, and
subcenter hospital in Manado during the period of
October 2015 to February 2016. Samples were
collected by consecutive sampling. Total
population consisted of 32 patients, divided into
two groups: 16 with normal pregnancies, and 16
threatened abortions that matched the inclusion
and exclusion criteria.
Inclusion criteria were single pregnant women
with less than 20 weeks of gestation confirmed
by ultrasound. Exclusion criteria were pregnant
women with history of recurrent pregnancy
loss,  those who were currently receiving
progesterone therapy, and fetal death or blighted
ovum.
Blood samples from subjects were collected, and
examined with PIBF ELISA-kit in the Prokita
Laboratory Manado.
Data were analyzed using T-test to investigate
the significance of PIBF value in the normal early
pregnancy and threatened abortion. Data were
processed using Statistical Product and Service
Solutions (SPSS) 22.0 for Windows.
RESULT
Subject Characteristics
Table 1. Maternal Age Frequency Distribution
Maternal age (year)
Total
<20 20­34 35
Groups Normal pregnancy 1 10 5 16
Threatened abortion 1 12 3 16
Total 2 22 8 32
Interpretation: most maternal age of subjects are around 20-34 years old.
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PIBF Serum Value
Our study showed that PIBF serum value of
threatened abortion was lower than normal
pregnancy in all groups of gestational age; with
details as follow: the first group of 4-8 weeks of
gestation (16.114 vs 48.62 ng/ml); in the second
group of 9-12 weeks of gestation (11.107 vs 41.909
ng/ml); in the third group of 13-16 weeks of
gestation (7.372 vs 54.217 ng/ml); while in the last
group of 17-20 weeks of gestation there was no
subject in the normal pregnancy group to compare
with the threatened abortion (12.151 ng/ml).
An overall calculation of our data showed a
significant difference of PIBF serum value in
normal pregnant women of  20 weeks and
threatened abortion (47.153 vs 11.540 ng/ml; p
value=0.000). Variable coefficient data showed that
the variation of PIBF serum in both groups were
above 10%, this stated that the PIBF serum were
not homogenous.
DISCUSSION
Pregnancy  immune­biology
Throughout history of human evolution,
humankind has developed a mechanism to protect
us from p a r a s i t e s  a n d  i n f e c t i o n s  b y
detecting and destroying foreign organic
materials that enter human’s body. This
mechanism is called the immune system.9
Fetus is a product of conception, which is a semi-
allograft tissue. However, there is no rejection from
the maternal immune system. This is due to the
absence of MHC class I nor class II on the placental
villous trophoblast, hence not inducing the NK
cytotoxic activities.10,11
Another factor protecting the fetus is the
expression of FasL, a protein membrane type II
that is commonly present in the immune-
compromised tissue, such as testes, cornea,
trophoblast (Houston, and O’Connell, 2004).12
Table 2. Educational Status Frequency Distribution
Educational status
Total
Elementary Junior high school High school Bachelor
Groups Normal pregnancy 2 1 9 4 16
Threatened abortion 4 6 5 1 16
Total 6 7 14 5 32
Interpretation: most educational status of subjects are at high school.
Table 3. Gravidity Status Frequency Distribution
Gravidity status
Total
First Multi
Groups Normal pregnancy 4 12 16
Threatened abortion 6 10 16
Total 10 22 32
Interpretation: most gravidity status of subjects are multiple.
Table 4. Gestational Age Frequency Distribution
Gestational age (weeks)
Total
4­8 9­12 13­16 17­20
Groups Normal pregnancy 7 6 3 - 16
Threatened abortion 1 4 2 9 16
Total 8 10 5 9 32
Interpretation: most gestational age of subjects are around 9-12 weeks.
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Wegmann (1993) mentioned that Th1 (pro-
inflammatory) and Th2 (anti-inflammatory)
balance is the key of successful pregnancy.
Whereas Th2 domination is required to protect
feto-placental unit from the adaptive immune
response,  or non-specific inflammatory
response.10,12
Pro-inflammatory cytokines are critical in the
early process of implantation to induce
angiogenesis. Shortly after, it should be replaced
by anti-inflammatory cytokines that shift the
balance from Th1 to Th2 dominance. Szekeres-
Bartho explained that TCD8+ cells in pregnant
women expressed progesterone receptors since
e a r l y  p r e g n a n c y .  W h e r e a s ,  u n d e r
progesterone influence, this lymphocyte cells
express a mediator protein with molecular weight
of 34kDa called PIBF (Progesterone-induced
blocking factor).3,5,10,12,13
The role of NK cells  in pregnancy
NK cells dominated the leucocytes involved in the
implantation process in early pregnancy. NK cells
are classified as peripheral NK cells and uterine NK
cells. In pregnancy, the amount of peripheral NK
cells is depleted due to the minimal expression of
CD16. This process is affected by the progesterone
level.14 In contrast to peripheral NK cells, uterine
NK cells are dominated in pregnancy. These NK
cells have a small effect of cytolysis hence needed
in pregnancy.14
Role of progesterone  in pregnancy
Progesterone is the main hormone in maintaining
pregnancy. It directly affects immune system or
through mediator PIBF. Depletion of progesterone
production in pregnancy will initiate parturition.
This is the main reason of progesterone supple-
mentation therapy as luteal support to prevent
abortion.15
PIBF as a research variable
As mentioned above, to have an immune-endocrine
effect, progesterone needs protein mediator which
is PIBF, which synthesized from the activated
lymphocyte of T/ (CD8+).1-3,5,7 Progesterone
supplementation is meant to improve PIBF value
through its binding to progesterone receptors, and
not to improve progesterone level.3-7,16
The mechanisms of PIBF in maintaining
pregnancy are through several pathways: by
inhibiting peripheral NK cells cytolysis activity, by
inducing Th2 cytokines domination and
asymmetric antibody production (Ig G).17-22
PIBF expression required adequate, hence PIBF
value will predicts the outcome of pregnancy.
This is according to the study done by B Polgar,
etc which stated that PIBF in the body liquid
will reflect the pathological condition of preg-
nancy.1,2,5,21,23
PIBF value can be measured through urine or
serum sample, this is due to the fact that the weight
molecule is 34kDa, there by small enough to be
excreted by renal of PIBF, this could be detected in
the urine. PIBF value measurement through urine
sample is often done because it is non invasive, yet
24 hours urine sample is needed to reduce the
bias.1-3,5 Nonetheless, in this study we use serum
sample, because it is considered the more consis-
tent result due to a random one time sampling.
Figure 1. Normally Progessing Pregnancy. A schematic hypothesis of immune-endocrinology in pregnancy. In normal
pregnancy, a sufficient concentration of progesterone leads to anti-inflammatory cytokines dominance (Th2), mediated by
PIBF expression.13
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A study performed by Igor Hudic found
difference between PIBF value in serum and urine,
nonetheless it has the same predictive value where
PIBF value in women with threatened abortion is
lower than in normal pregnancy.2 This is consistent
with our study which found that PIBF serum value
in threatened abortion is significantly lower than
in normal pregnancy.
PIBF Serum Value
Previous studies have shown that PIBF has a role
in maintaining pregnancy through immunological
mechanism by modulating cytokine Th1/Th2
balance, suppressing cytotoxic and cytolysis
activity of NK cells, and by increasing asymmetric
antibody production.1-3,5,7,13,19
Our study showed that there were significant
difference between PIBF serum value in normal
pregnant women  20 weeks (47.153  23.830)
and threatened abortion (11.540  4.892) (p
value=0.000). This result is consistent with several
studies which suggested that the presence of PIBF
could be used as a biomarker of predicting the
outcome of pregnancy or detecting pathological
condition of pregnancy.1,2,5
Our study showed that the coefficient variation
is above 10%, meaning that PIBF value has a large
variation. This might be due to the factors beyond
the researcher control which cause the difference
of progesterone production such as inflammatory
process, different fetal development, infection
factor, uterine stretch, or the maternal/fetal
stress.24 Similar studies performed before also
have the same conclusion where mean PIBF in
threatened abortion is lower significantly
compared to normal pregnancy. Despite having
different value, this may due to the different study
methods, reagents, processing methods, wave
length used in ELISA reader, samples amount, and
gestational age used in the subjects.
This study showed that PIBF could be used as a
biomarker of pathologic process in pregnancy.
However, due to the cross-sectional study design,
it is not possible to determine the cut-off point of
PIBF value required to maintain pregnancy.
CONCLUSIONS
PIBF serum value of pregnant women  20 weeks
with threatened abortion were significantly lower
compared to normal pregnancy. This also showed
that PIBF value could be used as a biomarker of a
pathologic process in pregnancy. PIBF could also
be used as a rational therapy in threatened
abortion. Further prospective studies are required
to determine the cut-off point of PIBF value
necessary to maintain pregnancy.
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